GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $41,000 | +10.8% | 1,271 | +20.5% | 0.01% | +20.0% |
| Q1 2022 | $37,000 | +19.4% | 1,055 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $31,000 | +19.2% | 1,055 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $26,000 | -25.7% | 1,055 | +5.2% | 0.00% | -40.0% |
| Q2 2021 | $35,000 | -86.7% | 1,003 | -84.5% | 0.01% | -86.8% |
| Q1 2021 | $263,000 | +2.3% | 6,462 | +8.9% | 0.04% | -7.3% |
| Q4 2020 | $257,000 | – | 5,935 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |